{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:10:53Z","timestamp":1785510653717,"version":"3.56.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Reviews in Mutation Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mrrev.2025.108570","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:01:19Z","timestamp":1763784079000},"page":"108570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Non-coding RNAs in Wilson\u2019s Disease: Plausible drivers of hepatic symptom heterogeneity"],"prefix":"10.1016","volume":"796","author":[{"given":"Neelanjana","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhrajit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4031-1810","authenticated-orcid":false,"given":"Mainak","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2025.108570_bib1","article-title":"Early Onset of Wilson's Disease and Possible Role of Disease-Modifying Genes: A Case Report and Literature Review","volume":"2024","author":"La Rosa","year":"2024","journal-title":"Case Rep. Hepatol."},{"issue":"3-4","key":"10.1016\/j.mrrev.2025.108570_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10534-006-9074-3","article-title":"Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level","volume":"20","author":"Bartee","year":"2007","journal-title":"Biometals"},{"key":"10.1016\/j.mrrev.2025.108570_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41525-020-0123-6","article-title":"ATP7B variant c.1934T\u2009>\u2009G p.Met645Arg causes Wilson disease by promoting exon 6 skipping","volume":"5","author":"Merico","year":"2020","journal-title":"NPJ Genom. Med."},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","article-title":"European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease","volume":"56","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13760-021-01816-w","article-title":"Correlation of ATP7B gene mutations with clinical phenotype and radiological features in Indian Wilson disease patients","volume":"122","author":"Chaudhuri","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib6","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.21037\/atm.2019.01.67","article-title":"Genetics and epigenetic factors of Wilson disease","volume":"7","author":"Medici","year":"2019","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.mrrev.2025.108570_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2023.04.026","article-title":"A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B With Wilson Disease in China","volume":"145","author":"Xue","year":"2023","journal-title":"Pedia Neurol."},{"issue":"1-2","key":"10.1016\/j.mrrev.2025.108570_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymgme.2005.05.004","article-title":"Mutation analysis of the ATP7B gene and genotype\/phenotype correlation in 227 patients with Wilson disease","volume":"86","author":"Vrabelova","year":"2005","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.mrrev.2025.108570_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2024.03.005","article-title":"An Effort to Identify Genetic Determinants in Siblings With Wilson Disease Manifesting Striking Clinical Heterogeneity: An Exome Profiling Study of Two Indian Families","volume":"155","author":"Saha","year":"2024","journal-title":"Pedia Neurol."},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114372","article-title":"Paradigm shift: microRNAs interact with target gene promoters to cause transcriptional gene activation or silencing","volume":"444","author":"Sarkar","year":"2025","journal-title":"Exp. Cell Res"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib11","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1038\/s41598-023-36503-8","article-title":"Comprehensive analysis of the coding and non-coding RNA transcriptome expression profiles of hippocampus tissue in tx-J animal model of Wilson's disease","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrrev.2025.108570_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41598-020-80635-0","article-title":"Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrrev.2025.108570_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.905513","article-title":"Construction of a Novel circRNA\/miRNA\/mRNA Regulatory Network to Explore the Potential Pathogenesis of Wilson's Disease","volume":"13","author":"Wei","year":"2022","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.21037\/atm.2019.01.20","article-title":"Clinical features of Wilson disease","volume":"7","author":"Stremmel","year":"2019","journal-title":"Ann. Transl. Med"},{"issue":"6808","key":"10.1016\/j.mrrev.2025.108570_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mrrev.2025.108570_bib16","first-page":"1287","article-title":"Wilson's Disease-Genetic Puzzles with Diagnostic Implications","volume":"13","author":"Gromadzka","year":"2023","journal-title":"Diagn. (Basel)"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1478-3231.2011.02661.x","article-title":"KH. Iron metabolism and the role of HFE gene polymorphisms in Wilson disease","volume":"32","author":"Pfeiffenberger","year":"2012","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.mrrev.2025.108570_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cld.349","article-title":"Wilson disease: Clinical manifestations, diagnosis, and treatment","volume":"3","author":"Schilsky","year":"2014","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"10","key":"10.1016\/j.mrrev.2025.108570_bib19","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"5","author":"Yang","year":"2024","journal-title":"MedComm (2020)"},{"issue":"12","key":"10.1016\/j.mrrev.2025.108570_bib20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41431-018-0221-4","article-title":"An MTF1 binding site disrupted by a homozygous variant in the promoter of ATP7B likely causes Wilson Disease","volume":"26","author":"Chen","year":"2018","journal-title":"Eur. J. Hum. Genet"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexcr.2014.01.013","article-title":"The role of Nrf1 and Nrf2 in the regulation of copper-responsive transcription","volume":"322","author":"Song","year":"2014","journal-title":"Exp. Cell Res"},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib22","doi-asserted-by":"crossref","first-page":"a005306","DOI":"10.1101\/mcs.a005306","article-title":"Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant","volume":"6","author":"Koboldt","year":"2020","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"6","key":"10.1016\/j.mrrev.2025.108570_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24459","article-title":"Genetic studies discover novel coding and non-coding mutations in patients with Wilson's disease in China","volume":"36","author":"Huang","year":"2022","journal-title":"J. Clin. Lab Anal."},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jmoldx.2022.10.002","article-title":"Pathogenicity of Intronic and Synonymous Variants of ATP7B in Wilson Disease","volume":"25","author":"Xu","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.mrrev.2025.108570_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120203","article-title":"Pathogenicity analysis of ATP7B in pediatric patients with Wilson's disease and functional verification of alternative splice variants","volume":"570","author":"Wang","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.mrrev.2025.108570_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00535-024-02135-6","article-title":"Profile of plasma microRNAs as a potential biomarker of Wilson's disease","volume":"59","author":"S\u00e1nchez-Monteagudo","year":"2024","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.mrrev.2025.108570_bib27","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/hmg\/8.9.1665","article-title":"Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation","volume":"8","author":"Buiakova","year":"1999","journal-title":"Hum. Mol. Genet"},{"issue":"Pt 6","key":"10.1016\/j.mrrev.2025.108570_bib28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/BST0361233","article-title":"Atp7b-\/- mice as a model for studies of Wilson's disease","volume":"36","author":"Lutsenko","year":"2008","journal-title":"Biochem Soc. Trans."},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2015.09.014","article-title":"Long-term metabolic correction of Wilson's disease in a murine model by gene therapy","volume":"64","author":"Murillo","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.30535","article-title":"Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice","volume":"70","author":"Murillo","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s12072-012-9348-5","article-title":"Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease","volume":"6","author":"Siaj","year":"2012","journal-title":"Hepatol. Int"},{"issue":"19","key":"10.1016\/j.mrrev.2025.108570_bib32","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.3390\/ijms21197368","article-title":"Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases","volume":"21","author":"Gholizadeh","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2025.108570_bib33","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.2147\/JIR.S489197","article-title":"Differential Expressions of circRNAs and Regulatory Mechanisms of ceRNA Network in Liver of Wilson's Disease TX Mice","volume":"17","author":"Chen","year":"2024","journal-title":"J. Inflamm. Res"},{"issue":"5","key":"10.1016\/j.mrrev.2025.108570_bib34","first-page":"1019","article-title":"Identification of Lncrna-Mrna Networks in Hepg2 Cells upon ATP7BKnockout and Copper Accumulation","volume":"52","author":"Yan","year":"2023","journal-title":"Iran. J. Public Health"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib35","first-page":"68","article-title":"Wilson's Disease with Acute Hepatic Onset: How to Diagnose and Treat It","volume":"11","author":"Delle Cave","year":"2024","journal-title":"Child. (Basel)"},{"issue":"12","key":"10.1016\/j.mrrev.2025.108570_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.mrrev.2025.108570_bib37","article-title":"The Roles and Mechanisms of lncRNAs in Liver Fibrosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib38","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.mrrev.2025.108570_bib39","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1080\/15384101.2015.1120917","article-title":"MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis","volume":"14","author":"Yu","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mrrev.2025.108570_bib40","article-title":"Long Non-coding RNA MALAT1: A Key Player in Liver Diseases","volume":"8","author":"Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.mrrev.2025.108570_bib41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/genes15101313","article-title":"Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122","volume":"15","author":"Colaianni","year":"2024","journal-title":"Genes (Basel)"},{"issue":"46","key":"10.1016\/j.mrrev.2025.108570_bib42","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.3748\/wjg.v23.i46.8140","article-title":"miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.mrrev.2025.108570_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20100297","article-title":"Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies","volume":"120","author":"Gui","year":"2011","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.mrrev.2025.108570_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int J. Mol. Med"},{"issue":"5","key":"10.1016\/j.mrrev.2025.108570_bib46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3892\/mmr.2021.12417","article-title":"miR221 regulates TGF-\u03b21-induced HSC activation through inhibiting autophagy by directly targeting LAMP2","volume":"24","author":"Cheng","year":"2021","journal-title":"Mol. Med Rep."},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hbpd.2019.05.002","article-title":"miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes","volume":"18","author":"Wang","year":"2019","journal-title":"Hepatobiliary Pancreat. Dis. Int"},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/ijms17030280","article-title":"MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma","volume":"17","author":"Hayes","year":"2016","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2025.108570_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2916243","article-title":"Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression","volume":"2019","author":"Murata","year":"2019","journal-title":"Biomed. Res Int"},{"issue":"6","key":"10.1016\/j.mrrev.2025.108570_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12072-020-10096-0","article-title":"Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism","volume":"14","author":"Li","year":"2020","journal-title":"Hepatol. Int"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib51","first-page":"70","volume":"82","author":"Wang","year":"2024","journal-title":"Ann. Biol. Clin. (Paris)"},{"issue":"3-4","key":"10.1016\/j.mrrev.2025.108570_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2017.10.149","article-title":"MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator","volume":"494","author":"Zhuge","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.mrrev.2025.108570_bib53","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.mrrev.2025.108570_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224820","article-title":"Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation","volume":"14","author":"Erhartova","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mrrev.2025.108570_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.13109","article-title":"Hepatic miR-33a\/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects","volume":"36","author":"Vega-Badillo","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.mrrev.2025.108570_bib56","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1159\/000366394","article-title":"Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease","volume":"34","author":"Feng","year":"2014","journal-title":"Cell Physiol. Biochem"},{"issue":"10","key":"10.1016\/j.mrrev.2025.108570_bib57","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00080.2016","article-title":"Lin28 and let-7: roles and regulation in liver diseases","volume":"310","author":"McDaniel","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/cells9041041","article-title":"The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jcm5030038","article-title":"Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis","volume":"5","author":"Kitano","year":"2016","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.mrrev.2025.108570_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"23","key":"10.1016\/j.mrrev.2025.108570_bib61","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.3390\/ijms20236084","article-title":"MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice","volume":"20","author":"Gan","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2025.108570_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2017.11.010","article-title":"miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis","volume":"10","author":"Zhou","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"10.1016\/j.mrrev.2025.108570_bib63","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/nu11112597","article-title":"mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance","volume":"11","author":"Meroni","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.mrrev.2025.108570_bib64","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/febs.12806","article-title":"Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease","volume":"281","author":"Ferreira","year":"2014","journal-title":"FEBS J."},{"issue":"36","key":"10.1016\/j.mrrev.2025.108570_bib65","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.mrrev.2025.108570_bib66","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1194\/jlr.M014654","article-title":"A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA","volume":"52","author":"Cazanave","year":"2011","journal-title":"J. Lipid Res"},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib67","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/hep.29209","article-title":"H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule","volume":"66","author":"Song","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mrrev.2025.108570_bib68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","article-title":"The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGF\u03b2 and Notch pathways","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib69","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hep.29034","article-title":"A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis","volume":"66","author":"Atanasovska","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.mrrev.2025.108570_bib70","first-page":"741","article-title":"[Expression profile of long non-coding RNA in non-alcoholic fatty liver disease]","volume":"42","author":"Sun","year":"2017","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"issue":"7","key":"10.1016\/j.mrrev.2025.108570_bib71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/jvh.12680","article-title":"Serum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients","volume":"24","author":"Yu","year":"2017","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib72","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.28882","article-title":"Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay","volume":"65","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mrrev.2025.108570_bib73","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/biom13030560","article-title":"LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review","volume":"13","author":"Zeng","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.mrrev.2025.108570_bib74","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/db17-0799","article-title":"Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.mrrev.2025.108570_bib75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cbin.11021","article-title":"LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR-27b\/23b\/24 in mice","volume":"42","author":"Zhou","year":"2018","journal-title":"Cell Biol. Int"},{"issue":"11","key":"10.1016\/j.mrrev.2025.108570_bib76","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.1002\/jcp.28714","article-title":"Long intergenic noncoding RNA p21 suppresses the apoptosis of hippocampus neurons in streptozotocin-diabetic mice by sponging microRNA-221 through upregulation of FOS","volume":"234","author":"Sun","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.mrrev.2025.108570_bib77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13578-020-00445-9","article-title":"An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer","volume":"10","author":"Amirinejad","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.mrrev.2025.108570_bib78","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.mrrev.2025.108570_bib79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/cells11020219","article-title":"TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells","volume":"11","author":"Petruzzelli","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.mrrev.2025.108570_bib80","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1194\/jlr.M081851","article-title":"Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway","volume":"59","author":"Fan","year":"2018","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.mrrev.2025.108570_bib81","doi-asserted-by":"crossref","unstructured":"Roy S., Ghosh S., Ray J., Ray K., Sengupta M. Missing heritability of Wilson disease: a search for the uncharacterized mutations. Mamm Genome. 2023 Mar;34(1):1-11. doi: 10.1007\/s00335-022-09971-y. Epub 2022 Dec 3. PMID: 36462057.","DOI":"10.1007\/s00335-022-09971-y"}],"container-title":["Mutation Research - Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574225000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574225000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:36:16Z","timestamp":1765560976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574225000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":81,"alternative-id":["S1383574225000419"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2025.108570","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in Wilson\u2019s Disease: Plausible drivers of hepatic symptom heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2025.108570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108570"}}